Jacobs Receives Contract to Support Bioprocessing Facility Project in Ireland

PASADENA, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Jacobs Engineering Group Inc. (NYSE: JEC) announced today that it received a contract from Ireland's National Institute for Bioprocessing Research and Training (NIBRT) to provide an integrated design team to support the development of a state-of-the-art facility in Dublin.

Jacobs is one of three leading contractors in Ireland that were selected to execute the project. Officials did not disclose the contract and investment values.

The new facility will enable biopharma firms to obtain practical hands-on competency based training programs within an environment that simulates the recognized standard for Good Manufacturing Practice. The project will provide pilot-scale and research laboratories and lecture and administrative facilities. From its Dublin office, Jacobs will perform project management; architectural design; and civil, structural, mechanical, and electrical services.

NIBRT was awarded funding of $100 million in a competitive bid funded by Industrial Development Agency (IDA) Ireland. NIBRT is an innovative research and educational institute in Bio-processing, headquartered in Dublin, which undertakes cutting-edge research in all aspects of bio-processing to better understand mechanistically the bio-production process, enabling process improvements and process monitoring to ensure product quality. This is achieved through its own research staff and in collaboration with University College Dublin, Trinity College Dublin, Dublin City University, and the Institute of Technology Sligo.

Commenting on the appointment of Jacobs to this project, NIBRT's CEO Maurice Treacy said, "We are excited to work with Jacobs on the design and development of this state-of-the-art showcase training and research bio-processing facility in Ireland that will enable us to provide the human capital skills needed to grow this industrial sector in Ireland."

In making the announcement, Jacobs Group Vice President Allyn Taylor stated, "For over 30 years, Jacobs has supported the growth of global biopharma firms that are based in Ireland. We are excited to assist NIBRT in the continued development of the country's bioprocessing industry."

Jacobs, with over 56,000 employees and revenues exceeding $10.0 billion, provides technical, professional, and construction services globally.

Any statements made in this release that are not based on historical fact are forward-looking statements. Although such statements are based on management's current estimates and expectations, and currently available competitive, financial, and economic data, forward-looking statements are inherently uncertain. We, therefore, caution the reader that there are a variety of factors that could cause business conditions and results to differ materially from what is contained in our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2007 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We also caution the readers of this release that we do not undertake to update any forward-looking statements made herein.

For additional information contact:

Michelle Jones

626.578.6968

SOURCE Jacobs Engineering Group Inc.